drugset / Trial / NCT02839421

Efficacy of Three Antibiotic Protocols for Aggressive Periodontitis Treatment

NCT02839421

Phase 4 Unknown 36 enrolled Facultad Nacional de Salud Publica
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The aim of the present study is to evaluate the clinical and microbiological efficacy of moxifloxacin or amoxicillin plus metronidazole in one-stage scaling and root planing in treating generalized aggressive periodontitis. Forty five subjects will be randomly allocated to 3 treatment groups. Subgingival plaque samples will be analysed for cultivable bacteria. The primary outcome variable to determine the superiority of one treatment over the others would be differences between groups for means CAL changes at 6 months post-treatment. Secondary outcome variables include differences between therapies for the mean changes in the mean levels of PD and the proportion of BOP.

Timeline

Start
2015-12
Primary completion
2019-05-31
Completion
2019-05-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Moxifloxacin Small molecule 400 mg